Authors:
Saxena, S
Winograd, A
Dunkin, JJ
Maidment, K
Rosen, R
Vapnik, T
Tarlow, G
Bystritsky, A
Citation: S. Saxena et al., A retrospective review of clinical characteristics and treatment response in body dysmorphic disorder versus obsessive-compulsive disorder, J CLIN PSY, 62(1), 2001, pp. 67-72
Authors:
Bystritsky, A
Maidenberg, E
Craske, MG
Vapnik, T
Shapiro, D
Citation: A. Bystritsky et al., Laboratory psychophysiological assessment and imagery exposure in panic disorder patients, DEPRESS ANX, 12(2), 2000, pp. 102-108
Authors:
Ackerman, DL
Greenland, S
Bystritsky, A
Small, GW
Citation: Dl. Ackerman et al., Side effects and time course of response in a placebo-controlled trial of fluoxetine for the treatment of geriatric depression, J CL PSYCH, 20(6), 2000, pp. 658-665
Authors:
Bystritsky, A
Saxena, S
Maidment, K
Vapnik, T
Tarlow, G
Rosen, R
Citation: A. Bystritsky et al., Quality-of-life changes among patients with obsessive-compulsive disorder in a partial hospitalization program, PSYCH SERV, 50(3), 1999, pp. 412-414
Authors:
Kronig, MH
Apter, J
Asnis, G
Bystritsky, A
Curtis, G
Ferguson, J
Landbloom, R
Munjack, D
Riesenberg, R
Robinson, D
Roy-Byrne, P
Phillips, K
Du Pont, IJ
Citation: Mh. Kronig et al., Placebo-controlled, multicenter study of sertraline treatment for obsessive-compulsive disorder, J CL PSYCH, 19(2), 1999, pp. 172-176
Authors:
Roy-Byrne, PP
Stein, MB
Russo, J
Mercier, E
Thomas, R
McQuaid, J
Katon, WJ
Craske, MG
Bystritsky, A
Sherbourne, CD
Citation: Pp. Roy-byrne et al., Panic disorder in the primary care setting: Comorbidity, disability, service utilization, and treatment, J CLIN PSY, 60(7), 1999, pp. 492-499